HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chiara Vendramin Selected Research

Thrombotic Thrombocytopenic Purpura

12/2021Shrinking Weibel-Palade bodies prevents high platelet recruitment in assays using thrombotic thrombocytopenic purpura plasma.
11/2019Characterization and treatment of congenital thrombotic thrombocytopenic purpura.
1/2019Administration of immunoglobulin G-degrading enzyme of Streptococcus pyogenes (IdeS) for persistent anti-ADAMTS13 antibodies in patients with thrombotic thrombocytopenic purpura in clinical remission.
1/2019Rituximab-induced acute and delayed serum sickness in thrombotic thrombocytopenic purpura: the role of anti-rituximab antibodies.
10/2018Anti-ADAMTS13 Autoantibodies against Cryptic Epitopes in Immune-Mediated Thrombotic Thrombocytopenic Purpura.
7/2018Bethesda Assay for Detecting Inhibitory Anti-ADAMTS13 Antibodies in Immune-Mediated Thrombotic Thrombocytopenic Purpura.
1/2017Presenting ADAMTS13 antibody and antigen levels predict prognosis in immune-mediated thrombotic thrombocytopenic purpura.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chiara Vendramin Research Topics

Disease

7Thrombotic Thrombocytopenic Purpura
12/2021 - 01/2017
2Acute Coronary Syndrome
09/2012 - 04/2009
1Brain Injuries (Brain Injury)
01/2020
1Ischemic Stroke
01/2020
1Transient Ischemic Attack
01/2020
1Abdominal Pain (Pain, Abdominal)
11/2019
1Headache (Headaches)
11/2019
1Stroke (Strokes)
11/2019
1Lethargy
11/2019
1Autoimmune Diseases (Autoimmune Disease)
11/2019
1Serum Sickness
01/2019
1Hepatitis C
01/2017
1Thrombotic Microangiopathies
01/2017
1Infections
09/2015
1Septic Shock (Toxic Shock Syndrome)
09/2015
1Sepsis (Septicemia)
09/2015
1ST Elevation Myocardial Infarction
09/2012
1Myocardial Infarction
10/2011
1B-Cell Lymphoma (Lymphoma, B Cell)
06/2008
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
07/2007
1Disease Progression
07/2007
1Lymphoma (Lymphomas)
11/2003

Drug/Important Bio-Agent (IBA)

4AntibodiesIBA
01/2019 - 01/2017
3thiamine triphosphorate (TTP)IBA
12/2021 - 01/2017
3Metalloproteases (Metalloproteinases)IBA
11/2019 - 07/2018
3DisintegrinsIBA
11/2019 - 07/2018
3ThrombospondinsIBA
11/2019 - 07/2018
2von Willebrand FactorIBA
12/2021 - 01/2020
1Intravenous Immunoglobulins (IVIG)FDA Link
11/2019
1Monoclonal AntibodiesIBA
11/2019
1EnzymesIBA
01/2019
1Rituximab (Mabthera)FDA Link
01/2019
1Immunoglobulin G (IgG)IBA
01/2019
1EpitopesIBA
10/2018
1AutoantibodiesIBA
10/2018
1AntigensIBA
01/2017
1Detergents (Detergent)IBA
01/2017
1PrionsIBA
01/2017
1SolventsIBA
01/2017
1Lactic Acid (Lactate)FDA LinkGeneric
09/2015
1Biomarkers (Surrogate Marker)IBA
09/2015
1Fibrinogen (Factor I)FDA Link
09/2012
1omega-Chloroacetophenone (Mace)IBA
09/2012
1TroponinIBA
10/2011
1Troponin IIBA
10/2011
1CreatinineIBA
04/2009
1pro-brain natriuretic peptide (1-76)IBA
04/2009
1Dihydrotachysterol (AT 10)IBA
06/2008
1Inosine Triphosphate (ITP)IBA
07/2007
1MethyltransferasesIBA
11/2003
1Death-Associated Protein KinasesIBA
11/2003

Therapy/Procedure

1Therapeutics
11/2019
1Aftercare (After-Treatment)
01/2017
1Plasma Exchange
01/2017
1Percutaneous Coronary Intervention
09/2012